By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

DURECT Corporation 

2 Results Way

Cupertino  California  95014  U.S.A.
Phone: 408-777-1417 Fax: 408-777-3577


SEARCH JOBS


Industry
Suppliers






Company News
DURECT (DRRX) Announces Second Quarter 2017 Financial Results And Provides Corporate Update 8/9/2017 12:24:44 PM
DURECT (DRRX) Release: ORADUR-Methylphenidate ER Capsule Achieves Primary Endpoint In Phase III Study In ADHD In Taiwan 8/8/2017 7:35:51 AM
DURECT (DRRX), Zogenix (ZGNX), Terminate Development and License Deal 8/3/2017 10:03:05 AM
DURECT (DRRX) Invites You To Join Its Second Quarter 2017 Earnings Conference Call 8/2/2017 12:27:53 PM
DURECT (DRRX) Completes Enrollment In PERSIST, Phase III Trial For POSIMIR 6/22/2017 6:34:21 AM
DURECT (DRRX)'s Collaboration With Sandoz Clears HSR Review And Is Effective 6/19/2017 8:53:07 AM
DURECT (DRRX) Announces First Quarter 2017 Financial Results And Provides Corporate Update 5/11/2017 9:05:10 AM
DURECT (DRRX) Invites You To Join Its First Quarter 2017 Earnings Conference Call 5/5/2017 9:55:02 AM
DURECT (DRRX) Announces Presentation Of Data From A Phase Ib Study Of DUR-928 In Nonalcoholic Steatohepatitis (NASH) At The International Liver Congress 2017 4/24/2017 7:37:00 AM
DURECT (DRRX) Announces Fourth Quarter And Full Year 2016 Financial Results And Update Of Programs 3/15/2017 9:50:20 AM
12345678910...
//-->